+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Gaucher Disease Market Size, Share and Growth Outlook, 2026: Analysis By Treatment Type (Enzyme Replacement Therapy , Substrate Reduction Therapy , Pharmacological Chaperones, Gene Therapy), By Disease Type (Type 1, Type 2, Type 3), By Route of Administration (Intravenous, Oral), By Patient Age Group (Pediatric, Adult, Geriatric), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Gaucher Disease Market size is forecast to increase from $1.95 Billion in 2026 to $2.43 Billion in 2034 at a CAGR of 2.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007317
Pages: 214 Pages

Gastroscopes Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Flexible Gastroscopes, Rigid Gastroscopes, Capsule Endoscopes, Single-use Gastroscopes, Dual-channel Gastroscopes), By Application (Diagnostic, Therapeutic, Screening, Research), By End User (Hospitals, Ambulatory Surgical Centers, Clinics, Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Gastroscopes Market size is forecast to increase from $3.75 Billion in 2026 to $6.59 Billion in 2034 at a CAGR of 7.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007316
Pages: 217 Pages

Gastroretentive Drug Delivery Systems Market Size, Share and Growth Outlook, 2026: Analysis By System Type (Floating Drug Delivery Systems, Bioadhesive , Expandable , High-Density ), By Dosage Form (Tablets, Capsules, Liquid Formulations, Microspheres ), By Therapeutic Application (Gastrointestinal Disorders, Diabetes Management, Central Nervous System , Infectious Diseases ), By End-Use (Pharmaceutical Manufacturers, Contract Development and Manufacturing Organizations , Biotechnology Companies, Research Laboratories), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Gastroretentive Drug Delivery Systems Market size is forecast to increase from $18.33 Billion in 2026 to $30.79 Billion in 2034 at a CAGR of 6.7% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007315
Pages: 226 Pages

Gastroparesis Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Prokinetic Agents, Antiemetic Agents, Proton Pump Inhibitors, Botulinum Toxin Injections, Antidepressants), By Disease Type (Diabetic Gastroparesis, Idiopathic Gastroparesis, Post-Surgical Gastroparesis, Viral & Neurological-Induced Gastroparesis), By Route of Administration (Oral, Injectable, Transdermal), By Drug Type (Prescription Drugs, Over-the-Counter ), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Gastroparesis Drugs Market size is forecast to increase from $5.13 Billion in 2026 to $7.41 Billion in 2034 at a CAGR of 4.7% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007314
Pages: 219 Pages

Gastrointestinal Therapeutics Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Biologics & Biosimilars, Proton Pump Inhibitors , Anti-Inflammatory Drugs, H2 Receptor Antagonists, Antispasmodics, Laxatives & Antidiarrheals, Antacids & Alginates), By Disease Indication (Inflammatory Bowel Disease , Gastroesophageal Reflux Disease , Irritable Bowel Syndrome , Peptic Ulcer Disease, Gastrointestinal Cancers, Gastrointestinal Infections), By Route of Administration (Oral Medications, Injectable Formulations, Rectal Preparations, Topical Applications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Specialty Clinics) Companies, and Country Forecast, 2021 to 2034

Global Gastrointestinal Therapeutics Market size is forecast to increase from $48.08 Billion in 2026 to $66.46 Billion in 2034 at a CAGR of 4.13% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007313
Pages: 216 Pages

Gastrointestinal Stromal Tumor (GIST) Therapeutics Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Marketed Drugs, Pipeline Drugs), By Drug Category (Tyrosine Kinase Inhibitors , Targeted Antibodies, Chemotherapy, Immunotherapy), By Route of Administration (Oral, Intravenous), By End-User (Hospitals & Oncology Clinics, Specialty Cancer Centers, Ambulatory Care Centers) Companies, and Country Forecast, 2021 to 2034

Global Gastrointestinal Stromal Tumor (GIST) Therapeutics Market size is forecast to increase from $896.51 Million in 2026 to $1634.95 Million in 2034 at a CAGR of 7.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007312
Pages: 230 Pages

Gastrointestinal Endoscopic Devices Market Size, Share and Growth Outlook, 2026: Analysis By Device Type (Flexible Endoscopes , Rigid Endoscopes, Capsule Endoscopes, Disposable Endoscopes, Robot-Assisted Endoscopes), By Component (Visualization Systems , Endotherapy, Endoscopic Accessories), By End-Use (Hospitals, Outpatient Facilities , Ambulatory Surgical Centers) Companies, and Country Forecast, 2021 to 2034

Global Gastrointestinal Endoscopic Devices Market size is forecast to increase from $11.9 Billion in 2026 to $18.12 Billion in 2034 at a CAGR of 5.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007311
Pages: 226 Pages

Gastrointestinal Diagnostics Market Size, Share and Growth Outlook, 2026: Analysis By Test Type (Endoscopy, Blood Tests , Stool-based Tests , Breath Tests , Biopsy & Imaging), By Technology (Polymerase Chain Reaction , Enzyme-Linked Immunosorbent Assay , Rapid Diagnostic Tests , Culture and Sensitivity Testing), By Application (Gastrointestinal Infections, Gastrointestinal Cancer, Inflammatory Bowel Disease , Gastroesophageal Reflux Disease ), By Test Location (Central Laboratories, Point-of-Care) Companies, and Country Forecast, 2021 to 2034

Global Gastrointestinal Diagnostics Market size is forecast to increase from $5.97 Billion in 2026 to $8.28 Billion in 2034 at a CAGR of 4.18% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007310
Pages: 213 Pages

Gastrointestinal Devices Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Endoscopy Devices , GI Surgical Devices, Bariatric Surgery Devices, GI Hemostasis Devices, GI Stent Devices, Enteral Feeding Devices, Biopsy Devices), By Disease Indication (Colorectal Cancer , Gastroesophageal Reflux Disease , Inflammatory Bowel Disease , Obesity, Biliary & Pancreatic Disorders), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers , Diagnostic Centers, Home Healthcare) Companies, and Country Forecast, 2021 to 2034

Global Gastrointestinal Devices Market size is forecast to increase from $13.8 Billion in 2026 to $21.02 Billion in 2034 at a CAGR of 5.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007309
Pages: 210 Pages

Gastroesophageal Reflux Disease Market Size, Share and Growth Outlook, 2026: Analysis By Solution Type (Diagnostics, Therapeutics), By Disease Phenotype (Non-Erosive Reflux Disease , Erosive Esophagitis, Barrett's Esophagus ), By Line of Therapy (First-Line Empiric Management, Maintenance , Refractory ), By Patient Demographics (Pediatric, Adult, Geriatric), By End User (Hospitals, Ambulatory Surgical Centers, Specialty , Home-care Settings) Companies, and Country Forecast, 2021 to 2034

Global Gastroesophageal Reflux Disease Market size is forecast to increase from $7.21 Billion in 2026 to $10.93 Billion in 2034 at a CAGR of 5.34% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007308
Pages: 218 Pages